| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698584 | Clinical Oncology | 2015 | 9 Pages |
Abstract
At this time point, observed toxicity is minimal with excellent local control rates. This promising treatment paradigm requires further investigation in the context of a randomised controlled trial to establish if the addition of SBRT to standard care improves survival outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K. Aitken, A. Tree, K. Thomas, C. Nutting, M. Hawkins, D. Tait, H. Mandeville, M. Ahmed, S. Lalondrelle, A. Miah, A. Taylor, G. Ross, V. Khoo, N. van As,